Fabino Enterprises Approves FY26 Audited Results

Fabino Enterprises Ltd (formerly Fabino Life Sciences Limited) announced the approval of audited standalone and consolidated financial results for the year ended March 31, 2026, during its board meeting held on May 23, 2026. The results comply with accounting standards and include statements of assets, liabilities, and cash flow. The board meeting commenced at 5:30 P.M. and concluded at 6:30 P.M. The Independent Auditors Report with unmodified opinion is enclosed as Annexure A.